$1.03
-0.03-2.83%
Last update: Oct 6, 10:38 AM
$1.06
-0.0043-0.41%
Marker Therapeutics Inc (MRKR) Stock Price, Quote, News & History
MRKRNASDAQ
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Marker Therapeutics (NASDAQ:MRKR) through any online brokerage.
Other companies in Marker Therapeutics’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Moderna Inc (NASDAQ:MRNA).
Marker Therapeutics has a consensus price target of $12.38.
The stock price for Marker Therapeutics (NASDAQ: MRKR) is $1.03 last updated October 6, 2026 at 10:38 AM EDT.
There are no upcoming dividends for Marker Therapeutics.
Marker Therapeutics does not have any upcoming earnings scheduled.
There is no upcoming split for Marker Therapeutics.
Marker Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Marker Therapeutics Inc is a clinical-stage immuno-oncology company specializing in the development and commercialization of novel T cell-based immunotherapies and peptide-based vaccines for the treatment of hematological malignancies and solid tumor...
